Healthcare Business Review: Pfizer & Mylan TEAM UP In Japan, Johnson & Johnson Gets RECALL Letter
Yesterday’s top stories;
Pfizer Inc. (NYSE:PFE) and Mylan Inc. (NASDAQ:MYL) will partner in an exclusive long-term strategic arrangement to develop, manufacture, distribute and market generic drugs in Japan. Through the terms, Pfizer will concentrate on the commercialization of the combined generics portfolio, along with marketing and sales, while Mylan will oversee operations, research and development and manufacturing.
Investing Insights: Intuit Inc. Earnings: A Mixed Bag.
Johnson & Johnson (NYSE:JNJ): A Medical Device Recall letter was issued by Synthes on July 5th, that requested medical facilities to go through their inventories and immediately cease the use of the identified part and lot numbers of the Hemostatic Bone Putty, as a potential exists that the material might ignite if contacted with electrosurgical cautery systems under certain conditions during surgery. The Putty is utilized to stop bone bleeding by establishing a physical barrier along the edges of bones which have been damaged by trauma or cut during a surgical procedure.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.